COVID Update: Masks are still required in health care settings, even if you’re fully vaccinated. Read our FAQs.

Scripps Health's Eric Topol on Statins and Diabetes Risk

Eric topol md 2010

What is more important: The benefit of taking a cholesterol-lowering statin drug to protect against heart attacks and strokes, or the increased risk of developing diabetes that might accompany the medication in some patients?


While a new study concluded that the heart-disease prevention benefits outweigh the diabetes risk, Scripps Clinic cardiologist Eric Topol, M.D., continues to warn against over prescribing the popular drugs.


“Although there is a narrow trade-off with the benefits of reducing heart disease, this paper doesn’t mitigate the (diabetes) concern to me,” the Scripps Health chief academic officer told The Wall Street Journal in a recent article about the study.


Dr. Topol also weighed in on the controversy in coverage by USA Today and The Boston Globe.


Read those full articles here:


USA Today – Aug. 10

The Boston Globe – Aug. 10

Media Contact

Keith Darce
858-678-7121
darce.keith@scrippshealth.org
Follow me: @KeithDarce